Sobre StandardX
A StandardX está a desenvolver uma plataforma compacta de aceleradores de partículas de alta potência, concebida para produzir vários isótopos a partir de uma instalação normalizada. Fundada em 2025, começa por se focar no fornecimento de isótopos para o diagnóstico e tratamento do cancro, a investigação e os futuros sistemas de fusão.
What StandardX offers
StandardX is developing a scalable production platform for rare isotopes used in medicine, industry and energy. Its compact particle-accelerator architecture is intended to produce a versatile portfolio including diagnostic and therapeutic medical isotopes, industrial isotopes and tritium for fusion energy.
What sets StandardX apart
StandardX is building a repeatable isotope-production platform rather than a facility dedicated to a single isotope. The compact accelerator architecture is designed to translate specialised nuclear physics into distributed, scalable production for materials that are currently scarce or constrained by centralised supply.